OSIP - OSI Pharmaceuticals Inc.

Your Recent Quotes: 0 | 0
Price Glossary Definition
38.28 -0.78
-2.00%
1/09/09 4:00
Open
39.90
Prev Close
39.06
Volume
559,233
52 Wk. Range
31.33- 53.71
Year-to-Date Performance Glossary Definition
UP 0.03%
Latest Dividend for OSIP
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
18.18
 
19.80
 
13.50
OSIP
Sect. Av.
S&P 500
Market Cap
2,211,877,000
Outstanding Shares
57,120,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy OSIP Rating Report
Rating History for OSIP
Target Price (1Yr)
High
60.00
Revenue
499,110,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
-9.20
6.97
0.98
Net Income
N/A
-1.39
0.00
EPS
N/A
-1.18
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-3.56
-9.33
40.96
Earnings Per Share($)

12/2005
 
 
 
-3.02
12/2006
 
 
 
-10.61
12/2007
 
 
 
1.15

Earnings for OSIP
EBITDA
116,994,000
Revenue
341,030,000
Outside Analyst Rating History

1/9/09
6
Buy
1/9/09
2
Hold
1/9/09
0
Sell

Jim Cramer Portfolio
Find out now if OSIP is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Latest OSIP Headlines
The company announces results of a crucial phase II study of the experimental cancer drug.

10:15AM 12/08/08

These heavily shorted biotech stocks could surge on any positive catalyst.

11:49AM 11/21/08

OSI Pharmaceuticals is up 5.7%.

3:55PM 11/19/08

GenVec's shares sank Wednesday despite what the company said was a positive update on its experimental pancreatic cancer drug TNFerad.

1:40PM 11/19/08

Amylin is down 20.1%.

3:57PM 11/12/08

Accuray falls 16%.

5:16PM 11/07/08

Sanofi-Aventis climbs, while Amylin falls.

3:37PM 10/28/08

Biotech stocks were falling along with the broader market Monday, but confirmation of Eli Lilly's bid lifted ImClone shares.

1:28PM 10/06/08

Genentech and OSI Pharmaceuticals said a late-stage study testing the combination use of Avastin and Tarceva failed to increase overall survival rates.

9:29AM 10/06/08

Exelixis slips lower on a soon-to-end collaboration with Glaxo.

4:19PM 06/27/08

Understanding the Market

Our Experts' Take at RealMoney for OSI Pharmaceuticals Inc.
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.

12:39PM 01/09/09

Once again, sentiment is in the driver's seat.

8:58AM 01/09/09

More Experts' Takes on OSIP


Premium Stock Ideas
Is Cramer trading OSIP in his Action Alerts Plus Portfolio?